Paper
Recent Development in Studies of Tetrahydroprotoberberines: Mechanism in Antinociception and Drug Addiction
Published Jun 1, 2008 · Hong-Yuan Chu, Guozhang Jin, E. Friedman
Cellular and Molecular Neurobiology
136
Citations
2
Influential Citations
Abstract
The tetrahydroprotoberberines (THPBs) are compounds isolated from Chinese herbs that possess a unique pharmacological profile as D2 dopamine receptor antagonists and D1 receptor agonists. l-Tetrahydropalmatine (l-THP) and l-stepholidine (SPD), members of the THPB family, were shown to have potential clinical use in the treatment of pain. However, their mechanism of action is not clear. In the past decades, Chinese scientists have made a great deal of effort to explore the mechanisms by which the THPBs and its analogues elicit antinociception and their potential utility in treating drug abuse. It is now clear that the antinociception produced by l-THP is related to inhibition of D2 dopamine receptors. The present review focuses on the recent progress made in understanding the mechanisms of l-THP- and l-SPD-mediated antinociception and the sequel of drug addiction.
Tetrahydroprotoberberines (THPBs) show potential in treating pain and drug addiction by inhibiting D2 dopamine receptors.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...